查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1997360

快速微生物检测市场：2026年至2032年全球市场预测（按产品类型、检测方法、检体类型、应用、目标病原体和最终用户划分）

Rapid Microbiology Testing Market by Product, Method, Sample Type, Application, Target Pathogen, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，快速微生物检测市场价值将达到 54.4 亿美元，到 2026 年将成长至 57.8 亿美元，到 2032 年将达到 93.4 亿美元，复合年增长率为 8.02%。

主要市场统计数据
基准年 2025 54.4亿美元
预计年份：2026年 57.8亿美元
预测年份 2032 93.4亿美元
复合年增长率 (%) 8.02%

透过探索关键驱动因素来展望快速微生物检测的未来：创新和市场动态如何影响微生物分析

快速微生物检测正逐渐成为现代微生物分析的关键支柱，为医疗、製药、工业和环境领域提供高速检测和鑑定能力。与传统培养方法相比，这些新方法显着缩短了检测时间，使临床医生能够更早启动标靶治疗，从而改善患者预后并遏制抗生素抗药性的蔓延。同时，食品、饮料、化妆品和生技产业的製造商也正在利用这些解决方案来保障公共安全、优化生产流程并遵守日益严格的全球法规。

技术进步、监管变革和数位化融合正在推动快速微生物检测领域的革命性变革。

在自动化、数据分析和检测化学领域突破性进展的推动下，快速微生物检测领域正经历一场变革。检查室越来越多地采用自动化微生物鑑定係统和高通量分子仪器，以在保持严格品质标准的同时，更快地获得检测结果。流式细胞技术和快速培养系统与基于核酸的检测方法相辅相成，透过提供关于细胞活力和病原体载量的多方面信息，重塑了所有医疗机构的诊断模式。

评估美国计划于 2025 年征收的关税对快速微生物检测的价值链、供应韧性和定价结构的累积影响。

计划于2025年对部分进口试剂、耗材和设备征收新关税，这将重塑快速微生物检测整个价值链的筹资策略和定价模式。供应商可能面临流式细胞技术染料、专有检测试剂盒和专用分子试剂采购成本的增加，这可能需要调整价格和重新谈判合约。检查室和工业品管团队本来就面临预算紧张的局面，现在可能需要调整采购週期和库存缓衝，以应对潜在的成本上涨。

从产品类型、方法、检体类型、应用、目标病原体和最终用户产业等方面分析快速微生物检测的关键细分见解。

对市场细分的深入理解揭示了快速微生物检测领域的成长机会和应用模式。从产品类型检验，耗材支援常规工作流程，而仪器则驱动处理能力和自动化。在仪器领域，自动化微生物鑑定係统、流式细胞技术平台、微生物检测解决方案、分子诊断设备和快速培养系统各自满足不同的应用情境。试剂和试剂盒是检测性能的基础，製造商正在开发模组化设计以简化验证和维护通讯协定。

揭示对美洲、欧洲、中东、非洲和亚太地区快速微生物检测市场的关键区域洞察。

区域趋势在快速微生物检测技术的普及和发展中起着至关重要的作用。在美洲，美国凭藉其雄厚的医疗基础设施资金和严格的监管要求，仍然是创新领域的领导者。同时，加拿大市场在医疗技术评估和公共检测实验室建设方面取得了进展。在拉丁美洲国家，为加强感染疾病监测和食品安全计划，对分子诊断平台的投资正在逐步增加，但预算限制和进口关税仍然影响采购决策。

快速微生物检测领域的主要企业、它们的策略倡议、推动市场发展的合作伙伴关係以及技术创新。

快速微生物检测市场正受到主要企业和新兴创新者策略倡议的影响。全球仪器製造商正透过收购、共同开发契约和针对自动化、多重检测和数位化连接等目标，拓展产品系列。除了这些成熟企业之外，一些专业的生技公司也在开拓细分市场，提供针对速度和准确性优化的耗材、试剂和试剂盒，并经常与学术机构合作检验新的检测方法。

为行业领导者提供切实可行的策略建议，以应对快速微生物检测市场的复杂性并最大限度地把握成长机会。

产业领导者应优先考虑实施全自动平台，将样品製备、检测和数据分析整合到统一的工作流程中。透过采用支援多种检测形式的模组化系统，企业可以优化资本支出并快速适应新的检测需求。同时，评估地理位置分散的替代试剂供应商将有助于缓解供应链中断和关税带来的成本压力。

为快速微生物检测市场分析提供支援的综合调查方法，强调资料收集的有效性和严格分析。

本分析结合了全面的二手资料研究和有针对性的一手资料研究，以确保资料的完整性和可操作的洞见。二手资料研究阶段包括对同行评审期刊、监管指南、专利资料库和公司新闻稿的深入审查，以明确技术趋势、检验要求和竞争定位。此外，还对仪器规格、试剂成分和性能声明等公开资讯与监管申报文件进行交叉核对，以检验关键技术声明的有效性。

快速微生物检测市场综合分析：关键发现、产业影响及相关人员策略展望

目前快速微生物检测的特点是最尖端科技的融合、监管趋势的加速发展以及相关人员需求的不断变化。我们的研究表明，自动化系统、分子检测和数位化整合正在共同推动微生物威胁检测和控制方式的模式转移。 2025年的关税趋势规划凸显了供应链弹性和在地采购策略的必要性，而区域差异则强调了根据监管、经济和基础设施实际情况客製化市场策略的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 快速微生物检测市场：依产品分类

  • 消耗品
    • 培养基
    • 试剂和试剂盒
    • 测试条
  • 装置
    • 自动化微生物鑑定係统
    • 流式细胞技术系统
    • 微生物检测系统
    • 分子诊断设备
    • 快速培养系统
  • 软体

第九章 快速微生物检测市场：依方法划分

  • 基于细胞成分的快速微生物检测
  • 基于生长的快速微生物检测
  • 基于核酸的快速微生物检测
  • 基于存活率的快速微生物检测

第十章检体类型分類的快速微生物检测市场

  • 血液培养
  • 呼吸道培养
  • 粪便培养
  • 尿液培养
  • 伤口培养

第十一章 快速微生物检测市场：依应用领域划分

  • 临床疾病诊断
  • 环境测试
  • 工业检验
    • 化妆品和个人保健产品测试
    • 食品和饮料检查
  • 製药和生物技术

第十二章 依目标病原体分類的快速微生物检测市场

  • 细菌
  • 真菌
  • 分枝桿菌
  • 寄生虫
  • 病毒

第十三章 快速微生物检测市场：依最终用户划分

  • 合约研究机构
  • 食品和饮料製造商
  • 检测机构和医院
  • 製药和生物技术公司

第十四章 快速微生物检测市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 快速微生物检测市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 快速微生物检测市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国快速微生物检测市场

第十八章：中国快速微生物检测市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Avantor, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Bruker Corporation
  • BTNX Inc.
  • Charles River Laboratories International, Inc.
  • Colifast AS
  • Danaher Corporation
  • Don Whitley Scientific Limited
  • Eurofins Scientific SE
  • Gradientech AB
  • Merck KGaA
  • NEOGEN Corporation
  • PerkinElmer, Inc.
  • Quidel Corporation
  • R-Biopharm AG
  • Rapid Micro Biosystems, Inc.
  • rqmicro AG
  • Sartorius AG
  • Serosep Ltd.
  • SGS SA
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
Product Code: MRR-5012464363FE

The Rapid Microbiology Testing Market was valued at USD 5.44 billion in 2025 and is projected to grow to USD 5.78 billion in 2026, with a CAGR of 8.02%, reaching USD 9.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.44 billion
Estimated Year [2026] USD 5.78 billion
Forecast Year [2032] USD 9.34 billion
CAGR (%) 8.02%

Setting the Scene for Rapid Microbiology Testing by Exploring Critical Drivers Innovations and Market Dynamics Shaping Microbial Analysis

Rapid microbiology testing has emerged as a critical pillar in modern microbial analysis, offering high-speed detection and identification capabilities across healthcare, pharmaceutical, industrial, and environmental settings. By dramatically reducing time-to-result compared to conventional culture methods, these new approaches empower clinicians to initiate targeted therapies sooner, thereby improving patient outcomes and curbing the rise of antimicrobial resistance. In parallel, manufacturers in food, beverages, cosmetics, and biotechnology leverage these solutions to safeguard public safety, optimize production workflows, and comply with increasingly stringent global regulations.

The drive for rapid detection technologies is fueled by the convergence of technological innovation and shifting stakeholder expectations. Automated instruments, molecular platforms, and viability assays are finding fresh relevance amid rising concerns over infection control and supply chain resilience. Regulatory agencies are moving toward harmonized guidelines that favor validated rapid methods, accelerating adoption in clinical laboratories and quality assurance divisions alike. Furthermore, heightened awareness around emerging pathogens and biosafety risks has amplified demand for robust, scalable testing strategies that can adapt to new threats with minimal downtime.

As the market landscape evolves, industry participants must synthesize technological capabilities, regulatory imperatives, and user requirements into cohesive adoption roadmaps. This introduction sets the stage for exploring transformative shifts, tariff impacts, segmentation insights, regional dynamics, key players, strategic recommendations, and the rigorous methodology underpinning our analysis.

Unveiling the Transformative Shifts Revolutionizing Rapid Microbiology Testing Through Technological Advances Regulatory Evolution and Digital Integration

The rapid microbiology testing landscape is experiencing transformative shifts driven by breakthroughs in automation, data analytics, and assay chemistry. Laboratories are increasingly integrating automated microbial identification systems and high-throughput molecular instruments to achieve faster turnaround times while maintaining stringent quality standards. Flow cytometry and rapid culture systems are complementing nucleic acid-based assays to provide multidimensional insights into cell viability and pathogen load, reshaping diagnostic paradigms across care settings.

In parallel, software-enabled platforms that harness artificial intelligence and machine learning are redefining how results are interpreted and reported. These digital solutions streamline data management, enable real-time remote monitoring, and support predictive maintenance, thereby enhancing operational efficiency and reducing manual errors. The seamless integration of instrument-level analytics with laboratory information management systems fosters a cohesive ecosystem in which decision-makers gain unprecedented visibility into testing workflows and outcomes.

On the regulatory front, accelerated approval pathways and the adoption of performance-based standards are encouraging industry pioneers to invest boldly in next-generation technologies. Harmonized guidelines across major regions are paving the way for more consistent validation approaches, minimizing redundancy and expediting market entry. Equally significant is the growing emphasis on point-of-care and near-patient testing modalities, which are decentralizing microbiology workflows and enabling rapid, on-site diagnostics in remote or resource-limited environments.

Together, these factors are catalyzing a fresh era of innovation, in which rapid microbiology testing transcends traditional boundaries to deliver actionable insights faster and with higher confidence than ever before.

Assessing the Cumulative Impact of United States Tariffs Set for 2025 on Rapid Microbiology Testing Value Chains Supply Resilience and Pricing Structures

The introduction of new tariffs on select imported reagents, consumables, and instrumentation slated for implementation in 2025 is set to reshape procurement strategies and pricing models across the rapid microbiology testing value chain. Suppliers may face higher input costs for flow cytometry dyes, proprietary assay kits, and specialized molecular reagents, which in turn could prompt adjustments in list prices and contract negotiations. Laboratories and industrial quality control teams, already managing tight budgets, will need to calibrate their purchasing cycles and inventory buffers to mitigate potential cost escalation.

These tariff measures also have broader implications for supply chain resilience and vendor diversification. Stakeholders are evaluating the strategic merits of near-shoring key production processes or forging partnerships with domestic manufacturers to reduce exposure to cross-border trade fluctuations. In some instances, organizations may accelerate validation of alternative reagents or instruments that originate from tariff-exempt regions, in order to preserve cost competitiveness and maintain service level agreements with critical customers.

Moreover, the cumulative impact of these duties could influence the pace of technology adoption in emerging markets, where price sensitivity is already high and healthcare budgets remain constrained. International manufacturers might recalibrate their go-to-market strategies by prioritizing localized distribution models and rebate programs to cushion end users from tariff-driven markups. At the same time, the evolving tariff landscape underscores the importance of proactive scenario planning, enabling both suppliers and end users to navigate shifting trade policies and safeguard uninterrupted access to vital testing resources.

Dissecting Key Segmentation Insights in Rapid Microbiology Testing Across Products Methods Sample Types Applications Pathogen Targets and End User Verticals

A nuanced understanding of market segmentation sheds light on growth opportunities and adoption patterns in rapid microbiology testing. When examining product categories, consumables support routine workflows while instruments drive throughput and automation; within instruments, automated microbial identification systems, flow cytometry platforms, microbial detection solutions, molecular diagnostic devices, and rapid culture systems each fulfill distinct use cases. Reagents and kits underpin assay performance, with manufacturers developing modular designs that streamline validation and maintenance protocols.

Method-based segmentation reveals how laboratories align analytical choices with sample characteristics and regulatory mandates. Cellular component-based approaches focus on targeted detection of cell wall markers, whereas growth-based methods emphasize expedited colony enumeration. Nucleic acid-based rapid testing leverages polymerase chain reaction and isothermal amplification to detect specific genetic sequences with high sensitivity, while viability-based assays distinguish live organisms from nonviable cells, informing infection control and sterility assessments.

Sample type further differentiates market dynamics, with blood culture driving clinical adoption, respiratory culture gaining momentum amid heightened respiratory disease surveillance, and stool, urine, and wound cultures addressing diagnostic and safety requirements in gastrointestinal, urinary tract, and surgical site contexts. Application segmentation highlights clinical disease diagnostics as a primary use case, while environmental testing extends to water and surface monitoring. Industrial testing encompasses both cosmetics and personal care products safety evaluations as well as food and beverage quality control, reflecting the sector's rigorous hygiene standards. Pharmaceutical and biotechnology applications round out this landscape by demanding sterility assurance and microbial control in drug development and manufacturing.

Target pathogen segmentation spans bacteria, fungi, mycobacteria, parasites, and viruses, each presenting unique analytical challenges. End users encompass contract research organizations, food and beverage companies, laboratories and hospitals, and pharmaceutical and biotechnology companies, with each group tailoring technology investments to their operational scope and regulatory priorities.

Uncovering Critical Regional Insights in Rapid Microbiology Testing Markets Across the Americas Europe Middle East & Africa and the Asia Pacific Landscape

Regional dynamics play a decisive role in shaping the adoption and evolution of rapid microbiology testing. In the Americas, the United States remains a technological innovator with robust funding for healthcare infrastructure and stringent regulatory requirements, while Canada's market advances health-technology assessments and public laboratory networks. Latin American countries are progressively investing in molecular platforms to bolster infectious disease surveillance and food safety programs, though budget constraints and import tariffs continue to influence procurement decisions.

Across Europe, the Middle East, and Africa, diverse regulatory frameworks and healthcare systems drive differentiated uptake. Western European nations leverage public-private collaborations and centralized reference laboratories, supporting the integration of advanced detection technologies. Regulatory convergence within the European Union streamlines market access, while the Middle East and North Africa are witnessing growing investments in diagnostic capacity building, particularly in urban healthcare centers. Sub-Saharan Africa, though still heavily reliant on traditional culture techniques, is gradually piloting rapid assays to combat infectious disease outbreaks and improve laboratory efficiency.

The Asia-Pacific region registers some of the fastest growth rates, propelled by expanding healthcare spending, rising awareness of foodborne hazards, and government initiatives to modernize laboratory networks. Japan and Australia continue to lead in innovation and regulatory harmonization, while China and India are fostering domestic manufacturing ecosystems for reagents and instruments. Southeast Asian nations, recognizing the importance of timely diagnostics in pandemic preparedness, are upgrading laboratory infrastructure and embracing point-of-care applications to extend testing access beyond urban centers.

These regional insights underscore the importance of tailored market entry strategies, nuanced partnerships, and regulatory intelligence to capitalize on the dynamic landscape of rapid microbiology testing worldwide.

Highlighting Leading Industry Players in Rapid Microbiology Testing and Their Strategic Initiatives Collaborations and Technological Innovations Driving Market Progress

The rapid microbiology testing market is shaped by the strategic initiatives of leading industry players and emerging innovators. Global instrument manufacturers are expanding their portfolios through acquisitions, joint development agreements, and targeted product launches that address automation, multiplexing, and digital connectivity. Alongside these incumbents, specialized biotech firms are carving niches by offering consumables, reagents, and kits optimized for speed and accuracy, often collaborating with academic centers to validate novel assay formats.

Partnerships between technology companies and clinical laboratories are accelerating real-world evidence generation, supporting regulatory submissions and facilitating early adopter programs. Technology providers invest in modular systems that accommodate evolving workflows, enabling labs to adopt plug-and-play upgrades rather than full platform replacements. Meanwhile, reagent specialists are driving down per-test costs by innovating stabilization chemistries and lyophilized formats, extending shelf life and simplifying cold chain requirements.

Emerging market entrants are leveraging software-as-a-service models to provide subscription-based access to interpretation algorithms and remote instrument monitoring. These digital offerings are complemented by global service networks, which ensure rapid instrument maintenance and supply replenishment-a critical capability in time-sensitive testing environments. Together, these developments reflect a marketplace that values lifecycle support, interoperability, and the seamless integration of hardware, chemistry, and data analytics.

Actionable Strategic Recommendations for Industry Leaders to Navigate Market Complexities and Capitalize on Growth Opportunities in Rapid Microbiology Testing

Industry leaders should prioritize the integration of fully automated platforms that combine sample preparation, detection, and data analytics in a unified workflow. By adopting modular systems that support multiple assay formats, organizations can optimize capital investments and adapt rapidly to emerging testing requirements. In parallel, evaluating alternative reagent suppliers with diversified geographic footprints will help mitigate supply chain disruptions and tariff-driven cost pressures.

Collaborating with regulatory authorities to shape performance-based validation standards can accelerate approval processes and foster broader acceptance of rapid methodologies. Establishing consortiums with peer organizations and academic institutions will facilitate data sharing and real-world performance benchmarking, enhancing collective confidence in novel technologies. Investing in workforce training programs is equally important; upskilling laboratory personnel in advanced analytical techniques and digital toolkits will maximize return on investment and improve operational resilience.

Expanding end-user engagement through tailored support services and outcome-oriented contracts can strengthen customer loyalty and drive repeat business. For example, outcome-based pricing models that align instrument performance metrics with client quality objectives will underscore the value proposition of rapid testing. Lastly, pursuing strategic alliances in high-growth regions and exploring point-of-care deployments will unlock new revenue streams while reinforcing organizational agility in a fast-evolving market.

Comprehensive Research Methodology Underpinning Rapid Microbiology Testing Market Analysis Emphasizing Data Collection Validation and Analytical Rigor

This analysis combines comprehensive secondary research with targeted primary engagements to ensure data integrity and actionable insights. The secondary phase involved a thorough review of peer-reviewed journals, regulatory guidelines, patent databases, and company publications to map technological trends, validation requirements, and competitive positioning. Publicly accessible information on instrument specifications, reagent formulations, and performance claims was cross-referenced with regulatory filings to validate key technical assertions.

In the primary research stage, we conducted in-depth interviews with laboratory managers, quality assurance directors, procurement officers, and industry experts across clinical, industrial, and environmental testing domains. These conversations provided firsthand perspectives on technology adoption barriers, budgetary constraints, and desired product enhancements. Market participants also shared insights on supply chain challenges, tariff impacts, and the evolving role of digital platforms in laboratory workflows.

Data triangulation was performed by comparing quantitative findings with qualitative feedback, ensuring that trends identified through survey data aligned with experiential observations from practitioners. Advanced analytical techniques, including scenario modeling and sensitivity analysis, were applied to interpret the potential effects of regulatory changes and tariff implementations. This rigorous methodology underpins the robustness of our conclusions and strategic recommendations.

Concluding Perspective on the Rapid Microbiology Testing Market Synthesizing Key Findings Industry Implications and Strategic Outlook for Stakeholders

The rapid microbiology testing landscape is defined by the convergence of cutting-edge technologies, regulatory momentum, and shifting stakeholder demands. Our exploration has revealed that automated systems, molecular assays, and digital integration are collectively driving a paradigm shift in how microbial threats are detected and managed. Tariff developments slated for 2025 accentuate the need for supply chain agility and localized sourcing strategies, while regional variations underscore the importance of customizing market approaches to regulatory, economic, and infrastructure realities.

Segmentation insights demonstrate that product innovation spans a broad spectrum-from consumables tailored for high-volume labs to specialized instruments designed for point-of-care applications. Methodological diversity enables tailored solutions across blood, respiratory, stool, urine, and wound testing, while applications in clinical, environmental, industrial, and pharmaceutical sectors illustrate the ubiquitous imperative for rapid, reliable microbial control. Emerging partnerships, subscription-based services, and outcome-oriented contracts signal a maturing market that values interoperability, real-world evidence, and lifecycle management.

Looking ahead, organizations that align strategic investments with evolving laboratory needs, regulatory expectations, and technological advances will be best positioned to capture value and drive sustainable growth. The insights and recommendations presented here serve as a roadmap for stakeholders intent on navigating the complexities of this dynamic market.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Rapid Microbiology Testing Market, by Product

  • 8.1. Consumables
    • 8.1.1. Culture Media
    • 8.1.2. Reagents & Kits
    • 8.1.3. Test Strips
  • 8.2. Instruments
    • 8.2.1. Automated Microbial Identification Systems
    • 8.2.2. Flow Cytometry Systems
    • 8.2.3. Microbial Detection Systems
    • 8.2.4. Molecular Diagnostic Instruments
    • 8.2.5. Rapid Culture Systems
  • 8.3. Software

9. Rapid Microbiology Testing Market, by Method

  • 9.1. Cellular Component-Based Rapid Microbiology Testing
  • 9.2. Growth-Based Rapid Microbiology Testing
  • 9.3. Nucleic Acid-Based Rapid Microbiology Testing
  • 9.4. Viability-Based Rapid Microbiology Testing

10. Rapid Microbiology Testing Market, by Sample Type

  • 10.1. Blood Culture
  • 10.2. Respiratory Culture
  • 10.3. Stool Culture
  • 10.4. Urine Culture
  • 10.5. Wound Culture

11. Rapid Microbiology Testing Market, by Application

  • 11.1. Clinical Disease Diagnostics
  • 11.2. Environmental Testing
  • 11.3. Industrial Testing
    • 11.3.1. Cosmetics & Personal Care Products Testing
    • 11.3.2. Food & Beverage testing
  • 11.4. Pharmaceutical & Biotechnology

12. Rapid Microbiology Testing Market, by Target Pathogen

  • 12.1. Bacteria
  • 12.2. Fungi
  • 12.3. Mycobacteria
  • 12.4. Parasites
  • 12.5. Viruses

13. Rapid Microbiology Testing Market, by End User

  • 13.1. Contract Research Organizations
  • 13.2. Food & Beverage Companies
  • 13.3. Laboratories & Hospitals
  • 13.4. Pharmaceutical & Biotechnology Companies

14. Rapid Microbiology Testing Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Rapid Microbiology Testing Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Rapid Microbiology Testing Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Rapid Microbiology Testing Market

18. China Rapid Microbiology Testing Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. Avantor, Inc.
  • 19.7. Becton, Dickinson and Company
  • 19.8. Bio-Rad Laboratories, Inc.
  • 19.9. bioMerieux SA
  • 19.10. Bruker Corporation
  • 19.11. BTNX Inc.
  • 19.12. Charles River Laboratories International, Inc.
  • 19.13. Colifast AS
  • 19.14. Danaher Corporation
  • 19.15. Don Whitley Scientific Limited
  • 19.16. Eurofins Scientific SE
  • 19.17. Gradientech AB
  • 19.18. Merck KGaA
  • 19.19. NEOGEN Corporation
  • 19.20. PerkinElmer, Inc.
  • 19.21. Quidel Corporation
  • 19.22. R-Biopharm AG
  • 19.23. Rapid Micro Biosystems, Inc.
  • 19.24. rqmicro AG
  • 19.25. Sartorius AG
  • 19.26. Serosep Ltd.
  • 19.27. SGS SA
  • 19.28. Siemens Healthineers AG
  • 19.29. Thermo Fisher Scientific, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL RAPID MICROBIOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REAGENTS & KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REAGENTS & KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TEST STRIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TEST STRIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY AUTOMATED MICROBIAL IDENTIFICATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FLOW CYTOMETRY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MICROBIAL DETECTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MICROBIAL DETECTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MICROBIAL DETECTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY RAPID CULTURE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY RAPID CULTURE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY RAPID CULTURE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CELLULAR COMPONENT-BASED RAPID MICROBIOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY GROWTH-BASED RAPID MICROBIOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY GROWTH-BASED RAPID MICROBIOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY GROWTH-BASED RAPID MICROBIOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY NUCLEIC ACID-BASED RAPID MICROBIOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY VIABILITY-BASED RAPID MICROBIOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY VIABILITY-BASED RAPID MICROBIOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY VIABILITY-BASED RAPID MICROBIOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BLOOD CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BLOOD CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BLOOD CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY RESPIRATORY CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY RESPIRATORY CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY RESPIRATORY CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY STOOL CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY STOOL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY STOOL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY URINE CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY URINE CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY URINE CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY WOUND CULTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY WOUND CULTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY WOUND CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CLINICAL DISEASE DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CLINICAL DISEASE DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CLINICAL DISEASE DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY ENVIRONMENTAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COSMETICS & PERSONAL CARE PRODUCTS TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD & BEVERAGE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FUNGI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FUNGI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FUNGI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MYCOBACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MYCOBACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY MYCOBACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PARASITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PARASITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PARASITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY VIRUSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY VIRUSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY VIRUSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES & HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES & HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY LABORATORIES & HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 210. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 211. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 213. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 216. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 217. GCC RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 239. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 240. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 241. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 242. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 243. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 246. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 247. G7 RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 250. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 251. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 253. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 256. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 257. NATO RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL RAPID MICROBIOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY METHOD, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY INDUSTRIAL TESTING, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY TARGET PATHOGEN, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA RAPID MICROBIOLOGY TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)